ASIT biotech

Trending Articles

  1. Counteracting counterfeits in the pharmaceutical supply chain Sreedhar Patnala, General Manager at Systech, discusses the comprehensive benefits of embracing traceability
  2. Olon commits to ultra-potent compound manufacturing expansion with new €25m facility The CDMO's integrated small and large-scale lines can produce payloads, linker payloads and ultra-potent APIs for customers across Europe
  3. Neogap Therapeutics and NorthX Biologics team up to scale novel cancer cell therapy CDMO NorthX Biologics will work with Neogap to determine advanced manufacturing protocols for Neogap's personalised cancer cell therapy
  4. New kinase inhibitor shows promise for treatment-resistant malaria The single-dose drug may be more effective than current treatments on the market, and works by disabling Plasmodium's ability to splice RNA
  5. Novo Nordisk acquires license to Ascendis Pharma's TransCon tech for up to $286m Novo Nordisk will use the technology to develop, manufacture and commercialise therapeutics for metabolic and cardiovascular diseases

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

Related Content

Manufacturing

ASIT biotech receives GMP certification for Belgian site

The Liège site manufactures in-house API for the biotech’s grass pollen allergies (gp-ASIT+) product
Research & Development

European patent granted to ASIT biotech

ASIT biotech announces the grant of a European patent on the active ingredients used in the ASIT+ allergy immunotherapy product candidates
Pharmaceutical

ASIT biotech appoints Gerd Zettlmeissl new Chair of the Board

Subscribe now